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Arrhythmias in children are often paroxysmal, complicating the ability to capture the abnor-
mal rhythm on routine ECG during an outpatient visit. The Alivecor Kardia Mobile (KM)
device is a wireless mobile health (mHealth) device that generates a single lead ECG tracing
with a FDA-approved algorithm for detection of atrial fibrillation in adults.
Objective
The goal of this study is to assess the accuracy of interval measurements on KM tracings by
directly comparing to standard 12-lead ECGs in pediatric patients.
Methods
This single center, prospective study enrolled pediatric outpatients, age <18 years present-
ing for cardiology clinic visits, into 3 groups based on age: 0–5 years, 6–10 years, and 11–
18 years. Patients were excluded if 12-lead ECG was not ordered during the visit. Each
enrolled subject underwent standard 12-lead ECG followed by 30-second KM tracing. ECG
parameters were batch read by 2 blinded pediatric electrophysiologists.
Results
Thirty patients were recruited with 10 patients/group. Structural heart disease and/or con-
duction abnormality was present in 20 patients (67%). Majority of tracings (27/30, 90%)
were of diagnostic quality on first attempt. Overall, the ΔPR was 15.2±10.8ms (r = 0.86),
ΔQRS was 9.6±8ms (r = 0.86), and ΔQTc was 15.6±12.7ms (r = 0.83). There were 9
patients with ΔQTc measurements >20ms with 4/9 (44%) having a conduction disorder and
2/9 (22%) having marked sinus arrhythmia. Bland-Altman method of agreement demon-
strated strong agreement for QRSd and QTc. The AF algorithm reported 4/30 (13%) false
positive "possible AF" diagnoses (rhythm over-read on KM demonstrated n = 3 marked
sinus arrhythmia, n = 1 sinus rhythm with aberrated PACs) resulting in a specificity of 87%.
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Conclusion
The Alivecor Kardia device produces accurate single lead ECG tracings in both healthy chil-
dren and children with cardiac disease or rhythm abnormalities across the pediatric spec-
trum. This mHealth application provides an accurate, non-invasive, real-time approach for
ambulatory ECG monitoring in children and adolescents.
Introduction
Cardiac arrhythmias are the most frequently encountered complication in children and adults
with history of congenital heart disease [1]. In addition to this population of children with con-
genital cardiac malformations, the American Heart Association’s Task Force on Children and
Youth (1993) reported that approximately 30,000 children develop a cardiac arrhythmia or are
born with an abnormality of cardiac conduction [2]. Arrhythmias in children are often parox-
ysmal, complicating the ability to capture the abnormal rhythm on routine electrocardiogram
during an outpatient visit. Current practice utilizes 24-hour ambulatory monitors, external
event monitors, or implantable loop recorders (ILR) to evaluate children with cardiac arrhyth-
mias. Disadvantages of these methods include cost, invasiveness (surgical placement of ILR),
sensitivity to lead adhesive, and inability to provide real-time access to transmitted ECG
tracings.
Smartphones are increasingly prevalent in today’s society and their ubiquity among chil-
dren and adolescents is no exception. Data suggest that 85% of teens and caregivers utilize
smartphones and 95% of teens are now “online.” [3] Advancements in wireless technology and
digital communication have led to the ability to perform health monitoring through mobile
technology. The AliveCor Kardia heart monitor (Smartphone monitor, AliveCor, San Fran-
cisco, CA, USA) provides a single-lead rhythm strip comparable to lead 1 on standard 12-lead
ECG machines using a smartphone. The Alivecor Kardia mobile device is commercially avail-
able as a direct to consumer product and does have FDA approval for use in adults with atrial
fibrillation. To date, there is no approved FDA indication for use in the pediatric population.
Haberman et al demonstrated that this method accurately detects baseline intervals, atrial rate,
and rhythm in diverse populations [4]. The monitor has also been studied in children. Nguyen
et al reported the ability of the Kardia device to generate diagnostic quality tracings, highlight-
ing the potential to improve outpatient management of pediatric cardiac arrhythmias [5]. In
this study, we aim to study the accuracy and usability of the Kardia monitor (KM) as compared
to standard 12-lead ECG in a pediatric outpatient setting. This is the first study to directly
compare these two modalities in pediatric patients.
Materials and methods
This prospective study received full approval from the Washington University in St. Louis’s
Institutional Review Board. Patients scheduled in the outpatient cardiology clinic were
recruited if they met the following inclusion criteria: 1) age< 18 years and 2) standard 12-lead
ECG ordered as part of routine visit testing. Written consent was obtained from the parent/
guardian and assent was also obtained for those patients12 years of age.
After consent was completed, patients and caregivers were instructed on how to use the
KM device. Patients were instructed to place 2 fingers of each hand on the respective device
electrodes. A 30-second lead 1 tracing was recorded using the KM iPhone application. KM
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Abbreviations: KM, Kardia mobile device; EP,
electrophysiologist; AF, atrial fibrillation.
tracings were performed either before or after 12-lead ECG tracings, not concurrently. Both
KM tracings and 12-lead ECG were saved and de-identified for offline analysis. Chart review
was also performed to obtain patient demographic data, cardiac history, and ECG indication.
Recruitment was continued until 30 patients were enrolled with 10 patients in each of the fol-
lowing groups: 0–5 years (group A), 6–10 years (group B), 11–18 years (group C).
For the older patients in group A, the most successful method to obtain KM tracings was to
have the patient sit on the caregiver’s lap facing outward, with the caregiver cupping their
hands around the child who would be holding on the electrodes, as if holding a book. For the
infants in group A, the most ideal positioning was to set their fingers on top of the KM elec-
trode either while they were in their caregiver’s lap or when they were lying on the exam table.
Obtaining a tracing in infants and toddlers frequently required two people to coordinate the
recording and appropriate finger positioning.
KM tracings and 12-lead ECGs were batch read by two board-certified pediatric electro-
physiologists (EP). ECG tracings from both the KM and 12-lead ECG were provided to review-
ers in both electronic and paper format for ease of reading and calculation. Heart rhythm,
heart rate, and interval measurements (RR, PR, QRS, QT, and QTc) were recorded. QTc was
calculated using Bazett’s formula [6]. All measurements from each EP for both the KM and
12-lead ECG tracings were averaged to account for inter-user variability. Perfect agreement
between modalities was defined as an absolute difference of<20 msec [7].
Statistical analysis
Summary data are presented as frequency with percentage. Descriptive statistics are presented
as means with range. The Bland-Altman method as well as correlation analysis was used to
compare interval agreement. Repeat measure analysis of variance (ANOVA) and student’s t-
test were used to compare differences in bias between age groups when appropriate. Statistical
significance was defines as a p-value 0.05.
Results
Demographics
Thirty patients were recruited with 10 patients/group with all patients in sinus rhythm at time
of data collection. Demographic data are presented in Table 1. The majority of tracings, 27/30
(90%), were diagnostic quality on first attempt with 3/30 (10%) requiring a second tracing to
obtain diagnostic data (See Fig 1). Specifically, one patient in group C and two patients in
group A needed to repeat the recording when the first recording terminated at< 30 seconds
for inadequate contact with the electrode in the former and for premature movement of fin-
gers off of the electrode for the latter. Congenital heart disease and/or conduction abnormali-
ties were present in 20/30 patients (67%).
Baseline intervals
When comparing all-comer KM versus 12-lead ECG parameters, the ΔPR was 15.2±10.8 msec
(r = 0.86), ΔQRS was 9.6±8 msec (r = 0.86), and ΔQTc was 15.6±12.7 msec (r = 0.83). There
was strong correlation between the KM-automated HR and the measured HR on KM (12.5
±12.2msec, r = 0.85) as well as when comparing the KM-automated HR and EP-calculated
12-ECG HR (11.2±12 msec, r = 0.87). Perfect agreement (within 20 msec variance) was seen in
28/30 (93%) for heart rate measurements and 114/150 (76%) of total interval measurements:
21/30 PR, 27/30 QRS, 19/30 QT, and 21/30 QTc measurements.
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KM QTc demonstrated very good agreement (bias = -2.6 msec; standard deviation of
bias = 20.2 msec) with the standard 12-lead ECG using the Bland-Altman measurement of
agreement. Fig 2(A) demonstrates that the difference in milliseconds of the QTc interval
between the KM and 12-lead ECG plotted against the mean of the 2 methods was clinically
non-significant.
In patients with absolute mean QTc difference >20 msec, 4/9 (44%) had conduction anom-
alies (PVCs, PACs, pre-excitation, BBB) and 2/9 (22%) had marked sinus arrhythmia. Only 2
patients (2/30, 6%) had a QTc absolute mean difference >30 msec with both patients having
underlying rhythm abnormalities (ventricular pacing; sinus arrhythmia with blocked PAC’s).
There was no statistical difference (p = 0.46) in the absolute mean difference in QTc measure-
ment between healthy children and children with underlying CHD/arrhythmia. A QTc inter-
val>450 msec was associated with an increased odds ratio (OR) of not achieving perfect
agreement (OR 7.06, 95% CI 1.07–54.09; p = 0.04). Despite this, the sensitivity and specificity
for detection of QTc>450 msec were 80% and 96%, respectively. The KM underestimated the
QTc in 15 patients (50%) by a mean of 18±8 msec with 10/15 (67%) patients having a diagnosis
of a congenital cardiac or conduction anomaly (p = 0.83).
Measurement of the QRS duration also exhibited strong agreement (bias -4.1 msec; stan-
dard deviation of bias = 11.9 msec; Fig 2(B)). Perfect agreement for QRS duration was seen in
Table 1. Demographic data. Patient demographic data is shown with descriptive statistical data. Abbreviations:
CoA = coarctation of the aorta, BAV = bicuspid aortic valve, VSD = ventricular septal defect, ASD = atrial septal defect,
SVC = superior vena cava, PV = pulmonary valve, JET = junctional ectopic tachycardia, HB = heart block,
LQTS = long QT syndrome, SVT = supraventricular tachycardia, WPW = Wolff-Parkinson-White syndrome.
Patient characteristics N (range/%)
Mean age (years) 8.2 (14 days-17 years)
Male 14 (47%)
Mean weight (kg) 38 (3.9–110.1)
Mean height (cm) 119 (50.8–172.7)
Cardiac Diagnosis(es)




Left SV with unroofed coronary sinus 1




Second degree HB 1
WPW 3
PVC 1
Inappropriate sinus tachycardia 2
LQTS Type 3 1
Neonatal SVT 1
Congenital Heart Disease + arrhythmia 3 (10%)
ASD + SVT 1
AVC defect + WPW 1
Shone’s Complex + CHB + pacemaker 1
https://doi.org/10.1371/journal.pone.0204403.t001
Can smartphone wireless ECGs be used to accurately assess ECG intervals in pediatrics?
PLOS ONE | https://doi.org/10.1371/journal.pone.0204403 September 27, 2018 4 / 9
27/30 (90%) patients. The KM underestimated the QRS duration in 17/30 (57%) patients with
a mean absolute difference of underestimation of 12±9msec.
The mean absolute difference and standard deviation for each age subgroup are displayed
in Table 2. There was no significant difference between subgroups.
Rhythm assessment
All patients were in sinus rhythm at the time of KM and 12-lead ECG acquisition. There were
no patients with sustained arrhythmia. Four patients had isolated premature atrial or ventricu-
lar contractions that were captured on either the KM or 12-lead ECG. Due to the serial acquisi-
tion of tracings, the isolated premature beats were captured on both modalities in one out of
these four patients. Rhythm interpretation on the KM tracing and 12-lead ECG was concor-
dant in 19/30 (63%) paired tracings read by EP#1 and 19/30 (63%) paired tracings read by
EP#2 (Table 3). Common discrepancies included normal sinus rhythm versus sinus arrhyth-
mia or sinus tachycardia identified on 4/30 readings by EP#1 and 6/30 readings by EP#2. In 1
patient with ventricular pacing, both overreaders interpreted the KM tracing as sinus rhythm
Fig 1. Side-by-side examples of serially acquired KM tracings and 12-lead ECGs exemplifying diagnostic quality of the KM for a patient in group A (panel A), group B
(panel B), and group C (panel C).
https://doi.org/10.1371/journal.pone.0204403.g001
Fig 2. Bland-Altman plots. These Bland Altman plots for QTc (2a) and QRS (2b) demonstrate strong levels of agreement between KM and 12-lead ECG.
https://doi.org/10.1371/journal.pone.0204403.g002
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with right bundle branch block versus “A-sensed/V-paced” on standard 12-lead ECG. The KM
accurately identified a patient with pre-excitation as well as a patient with 1st degree AV block.
Atrial Fibrillation (AF) algorithm
There were no patients with documented AF based on EP interpretations of KM and 12-lead
ECG tracings. However, the KM AF algorithm reported 4/30 (13%) false positive “possible
Table 2. Variance between Smartphone Monitor and 12-lead ECG parameters. There was no statistical difference in average absolute mean difference for interval mea-
surements between groups.
Group A (n = 10) Group B (n = 10) Group C (n = 10) p-value
PR 12.2 ± 10.7 18.1 ± 9.6 15.5 ± 11.6 0.4
QRSd 6.2 ± 5.4 10.1 ± 7 12.4 ± 10.4 0.2
QT 22.9 ± 27.6 15.8 ± 12.2 21.9 ± 19.7 0.7
QTc 11.2 ± 7 14.1 ± 8.5 21.6 ± 18.3 0.2
https://doi.org/10.1371/journal.pone.0204403.t002
Table 3. Rhythm interpretation and comparison by two pediatric electrophysiologists. Abbreviations: SR = sinus rhythm, ST = sinus tachycardia, SB = sinus bradycar-
dia, SAR = sinus arrhythmia, PAC = premature atrial contraction, PVC = premature ventricular contraction, IRBB = incomplete right bundle branch block.
KM RHYTHM INTERPRETATION 12-LEAD ECG RHYTHM INTERPRETATION
Patient KM Automated EP #1 EP #2 EP #1 EP #2
1 Possible AF SR SR with SAR SR SR
2 SR SR SR SR
3 SR with long PR SR with prolonged AV
conduction
SB with 1st degree AVB SB with 1st degree
AVB
4 SR with PVCs SR with PVCs SR with PVCs in trigeminy and
quadrigeminy
SR with frequent PVCs
5 ST ST SR SR
6 Normal SR with RBBB SR with RBBB A sensed/V paced A sensed/V paced
7 SB with SAR SB with SAR SB SB
8 Normal SR with SAR; prolonged QT SR with SA SR SAR with blocked PACs SR with blocked PACs
9 Normal SR SR SR SR
10 Normal SR SR SR SR
11 Normal SR with preexcitation SR with preexcitation SR, SAR, WPW SR with WPW
12 Normal SR SR SR with LQTS SR
13 SR with SAR SR with SAR SR SAR SR with SAR
14 Possible AF SR SR SR SR
15 Normal SR SR SR SR with SAR
16 Normal SR with PVCs SR with PVCs SR with SAR SR
17 Normal SR SAR SR SR SR
18 Normal SR SAR SR with SA SR SR
19 SR/ST SR ST SR
20 SR SR SR, IRBBB SR
21 Normal SR SR SR SR
22 SR SR SR SAR SR with SAR
23 SR SR SR SR
24 Possible AF SR/ST SR with SAR SR SAR SR
25 Unreadable SR SR SR SR
26 SR SAR SR with SAR SR SAR SR with SAR
27 Possible AF ST with PACs with
aberrancy
SR with PAC ST ST
28 SR/ST ST SR SR
29 SR/SAR SR with SAR SR SAR SR with SAR
30 SR/SAR SR with SAR SR SAR SR with SAR
https://doi.org/10.1371/journal.pone.0204403.t003
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AF” diagnoses with EP over-reads reporting sinus tachycardia with sinus arrhythmia (n = 3)
and sinus tachycardia with aberrantly conducted PACs (n = 1) resulting in a specificity 87%
and negative predictive value of 100%.
Discussion
This is the first study to directly compare electrocardiographic intervals measured from the
KM device to the standard 12-lead ECG in pediatric patients. The data show that the Kardia
device can accurately monitor heart rate, rhythm, and interval lengths in children. Healthy
children as well as children with underlying congenital heart defects or arrhythmias were
included in this study, supporting the generalizability for use of this device in this population.
Importantly, all tracings obtained in this study were of diagnostic quality despite 3 patients
requiring a second tracing. These diagnostic quality tracings allow providers the ability to
remotely treat the identified arrhythmia and triage for further evaluation.
Like others in the literature, this study reveals excellent agreement for heart rate measure-
ment in all age groups. This highlights the potential for the KM device to be used in the outpa-
tient monitoring of heart rate as well as for work-up of palpitations. Age-related compliance
has been identified as a barrier to attaining legible ECG data using event-triggered monitoring
[8]. The ease of use and accuracy of the KM device makes this an ideal alternative approach for
capturing time-sensitive events in young children. These features of the device could also
potentially lead to decreased levels of anxiety among these patients who often experience
increased levels of stress during diagnostic ECG testing.
Baseline interval agreement was superior to that documented in prior studies. For example,
QTc absolute mean difference in this study was 15.6±12.7msec compared to that reported by
Haberman et al with mean difference of 33±44 msec in a cohort investigating division I ath-
letes, healthy subjects, and cardiology clinic patients [4]. This is the first direct comparison of
QTc intervals specifically in the pediatric population and results for QTc interval measurement
are promising when compared to those obtained in the young adult population. The other
interval measurements in this study achieved a similar degree of agreement. Our definition of
perfect agreement <20msec has been chosen as an aggressive cutoff point in previous studies
[6], and the majority of tracings (76%) achieved perfect agreement between the Kardia device
and 12-lead ECG.
Absolute mean difference of>20msec was most common in QT and QTc measurement
comparisons. Neither age group nor presence of underlying cardiac diagnosis predicted
increased differences in absolute mean difference for these intervals. The etiology for bias in
these measurements is multifactorial. The Kardia tracings were obtained within 30 minutes of
12-lead ECG acquisition thus leading to the possibility of variability in heart rate and auto-
nomic tone. From direct observation as well as previous literature, the KM is sensitive to
motion artifact (muscle tremor, arm movement, muscle tension) and background noise. These
parameters are difficult to control for in the pediatric setting. In addition, the average of mea-
surements from two electrophysiologists was used for comparison calculations and, therefore,
inter-user variability may have also contributed. Despite these facts, the KM device had a high
specificity for detecting a QTc>450 msec and would thus be an effective outpatient tool for
monitoring patients with prolonged QTc.
Similarly, QRS duration data exhibited excellent agreement. Although the KM monitor
underestimated the QRS duration in the majority of patients, the absolute mean difference in
measurements was small (12±9msec) and unlikely to have clinical significance. Thus, the KM
monitor would be useful in differentiation of narrow versus wide-complex tachycardias in the
outpatient setting.
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Agreement in rhythm assessment was seen in the majority of patients. All patients were in
sinus rhythm and there were no cases of sustained tachycardia. Ferdman et al has published
data supporting the use of the smartphone ECG in diagnosing pediatric SVT, including accu-
racy in detecting mechanism [9]. Additionally, the specificity of the KM AF algorithm in this
study was high. Other studies have documented excellent sensitivity and specificity for detec-
tion of AF in the adult population. Our study did not specifically target this group and further
studies would be needed to validate the AF algorithm in the pediatric population.
The Kardia mHealth device is an effective and efficient device. Patients and/or caregivers
were easily able to follow instructions on how to use the KM monitor. Further usability of the
device has been previously analyzed by Nguyen et al who assessed for user satisfaction in pedi-
atric patients with paroxysmal arrhythmias [5]. In that study, 98% of survey responses indi-
cated it was easy to obtain tracings, 93% found it easy to transmit tracings, and 98% showed
added comfort in managing their own or their child’s arrhythmia by having the device. The
KM’s ease of use combined with its accurate results supports the incorporation of this device
into the outpatient management of arrhythmias in children [10].
Study limitations
There are multiple limitations in this study. First, this is a single center design limiting the gen-
eralizability of the results. Additionally, the sample size of 30 patients did not allow for more
complex analysis of validity of measurements across age groups or diagnosis. The KM and
12-lead ECGs were obtained serially rather than concurrently leading to potential variability in
heart rate and interval measurements. This is certainly a limitation of the study; however, this
study design was chosen to attempt to optimize the data quality of tracings obtained from
younger patients as concurrent acquisition would have been technically challenging in the
infant to early childhood age groups. Lastly, interval measurements were batch read by two
electrophysiologists. Although this method of calculation was necessary to account for inter-
user variability, it also likely contributed to differences in measurement between the KM and
12-lead ECG.
Conclusion
The Alivecor Kardia mHealth device produces accurate single lead ECG tracings in both
healthy children and children with underlying cardiac disease or rhythm abnormalities across
the pediatric spectrum. This mHealth device provides an accurate, non-invasive, and real-time
approach for ambulatory ECG monitoring in children and adolescents.
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